RxDoctor Payments Data

Daniela Gitlin, MD

Psychiatry · Plattsburgh, NYNPI 1235211228

Payments from drug & device makers

$398in general payments, 2019–2025

Across 27 payments — averaging $14.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$150
  • Sunovion Pharmaceuticals Inc.$82
  • Lundbeck LLC$59
  • Takeda Pharmaceuticals U.S.A., Inc.$50
  • Neurocrine Biosciences, Inc.$16
  • Vanda Pharmaceuticals Inc.$15
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$398100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$398 in reported general payments places this provider in the 65th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$9,302
Medicare patients
11
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl18$33,051
RexultiBrexpiprazole14$20,811
TrintellixVortioxetine Hydrobromide16$16,761
Lurasidone Hcl11$5,797
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine49$5,584
Alprazolam ErAlprazolam35$3,968
Methylphenidate ErMethylphenidate Hcl14$2,181
Quetiapine Fumarate ErQuetiapine Fumarate39$1,789
Desvenlafaxine Succinate ErDesvenlafaxine Succinate51$1,483
Bupropion Hcl SrBupropion Hcl78$1,171
Clonazepam102$1,018
Alprazolam XrAlprazolam16$728
Methylphenidate Hcl29$728
Gabapentin37$696
Lamotrigine26$627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$150$33,05118 claims
Otsuka America Pharmaceutical, Inc.Rexulti$13$20,81114 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$50$16,76116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Plattsburgh

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →